Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 14, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 148
- +6 vs. Q2 2025
- Portfolio value
- $4.81B
- +$275.6M (+6.1%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 5,514 | $26.9K | <0.1% | 00.0% | Unchanged | History |
| MTDMettler Toledo International Inc | COM | 42 | $51.6K | <0.1% | 00.0% | Unchanged | History |
| QCOMQualcomm Inc | Stock | 447 | $74.4K | <0.1% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 825 | $77.7K | <0.1% | −6,940−89.4% | Reduced | History |
| AMRXAmneal Pharmaceuticals, Inc. | COM STK CL A | 7,913 | $79.2K | <0.1% | +7,913 | New | History |
| GMABGenmab A/S | SPONSORED ADS | 3,009 | $92.3K | <0.1% | +3,009 | New | History |
| CORTCorcept Therapeutics Inc | COM | 1,227 | $102.0K | <0.1% | +1,227 | New | History |
| AAgilent Technologies, Inc. | COM | 806 | $103.5K | <0.1% | 00.0% | Unchanged | History |
| MSFTMicrosoft Corp | Stock | 203 | $105.1K | <0.1% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 2,100 | $115.4K | <0.1% | −1,641−43.9% | Reduced | History |
| ORCLOracle Corp | Stock | 417 | $117.3K | <0.1% | −237−36.2% | Reduced | History |
| GHGuardant Health, Inc. | COM | 1,953 | $122.0K | <0.1% | +1,953 | New | History |
| ZTSZoetis Inc. | Stock | 872 | $127.6K | <0.1% | +215+32.7% | Added | History |
| NVDANVIDIA Corp | Stock | 702 | $131.0K | <0.1% | −49−6.5% | Reduced | History |
| PTCTPTC Therapeutics, Inc. | COM | 2,530 | $155.3K | <0.1% | −1,270−33.4% | Reduced | History |
| ALKSAlkermes plc. | SHS | 6,594 | $197.8K | <0.1% | +6,594 | New | History |
| KRYSKrystal Biotech, Inc. | COM | 1,312 | $231.6K | <0.1% | +62+5.0% | Added | History |
| MRNAModerna, Inc. | Stock | 9,341 | $241.3K | <0.1% | −1,229,327−99.2% | Reduced | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 35,052 | $251.3K | <0.1% | +32,052+1,068.4% | Added | History |
| GOOGLAlphabet Inc. | Stock | 1,082 | $263.0K | <0.1% | −368−25.4% | Reduced | History |
| BIDUBaidu, Inc. | ADR | 2,000 | $263.5K | <0.1% | 00.0% | Unchanged | History |
| QUREuniQure N.V. | SHS | 4,763 | $278.0K | <0.1% | −14,847−75.7% | Reduced | History |
| CAICaris Life Sciences, Inc. | COM | 9,605 | $290.6K | <0.1% | −395−4.0% | Reduced | History |
| METAMeta Platforms, Inc. | Stock | 400 | $293.8K | <0.1% | +400 | New | History |
| PFEPfizer Inc | Stock | 11,827 | $301.4K | <0.1% | −59,088−83.3% | Reduced | History |
| EXELExelixis, Inc. | COM | 7,361 | $304.0K | <0.1% | −1,139−13.4% | Reduced | History |
| SMMTSummit Therapeutics Inc. | COM | 18,982 | $392.2K | <0.1% | −22,756−54.5% | Reduced | History |
| AMZNAmazon Com Inc | Stock | 1,812 | $397.9K | <0.1% | +662+57.6% | Added | History |
| TEMTempus AI, Inc. | CL A | 5,013 | $404.6K | <0.1% | +4,776+2,015.2% | Added | History |
| AAPLApple Inc. | Stock | 1,609 | $409.7K | <0.1% | +1,609 | New | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 14,611 | $415.5K | <0.1% | −5,944−28.9% | Reduced | History |
| SNYSanofi | SPONSORED ADR | 8,860 | $418.2K | <0.1% | +8,860 | New | History |
| PLNTPlanet Fitness, Inc. | CL A | 4,301 | $446.4K | <0.1% | +1,601+59.3% | Added | History |
| RPRXRoyalty Pharma plc | SHS CLASS A | 12,961 | $457.3K | <0.1% | +12,961 | New | History |
| GRMNGarmin Ltd | SHS | 2,031 | $500.1K | <0.1% | +1,181+138.9% | Added | History |
| iShares Russell 2000 ETF464287655 | ETF | 2,300 | $556.5K | <0.1% | 00.0% | Unchanged | – |
| BIIBBiogen Inc. | COM | 4,213 | $590.2K | <0.1% | +3,811+948.0% | Added | History |
| DOCSDoximity, Inc. | CL A | 9,693 | $709.0K | <0.1% | −14,123−59.3% | Reduced | History |
| CERTCertara, Inc. | COM | 59,447 | $726.4K | <0.1% | −22,293−27.3% | Reduced | History |
| BKDBrookdale Senior Living Inc. | COM | 104,665 | $886.5K | <0.1% | +104,665 | New | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 9,053 | $914.3K | <0.1% | −11,853−56.7% | Reduced | History |
| MLYSMineralys Therapeutics, Inc. | COM | 26,605 | $1.01M | <0.1% | +11,049+71.0% | Added | History |
| BBIOBridgeBio Pharma, Inc. | COM | 20,356 | $1.06M | <0.1% | +9,956+95.7% | Added | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 2,393 | $1.10M | <0.1% | +1,293+117.5% | Added | History |
| UTHRUnited Therapeutics Corp | COM | 2,640 | $1.11M | <0.1% | +2,640 | New | History |
| BBNXBeta Bionics, Inc. | COM | 64,283 | $1.28M | <0.1% | −2,542−3.8% | Reduced | History |
| AVTRAvantor, Inc. | COM | 103,362 | $1.29M | <0.1% | +103,362 | New | History |
| PTGXProtagonist Therapeutics, Inc | COM | 20,581 | $1.37M | <0.1% | +1,109+5.7% | Added | History |
| VanEck ETF Trust92189F106 | GOLD MINERS ETF | 18,500 | $1.41M | <0.1% | −7,700−29.4% | Reduced | – |
| CORCencora, Inc. | Stock | 4,850 | $1.52M | <0.1% | −3,120−39.1% | Reduced | History |
| BAXBaxter International Inc | Stock | 68,084 | $1.55M | <0.1% | −84,207−55.3% | Reduced | History |
| VKTXViking Therapeutics, Inc. | COM | 76,082 | $2.00M | <0.1% | +76,082 | New | History |
| SPYSPDR S&P 500 ETF Trust | ETF | 3,100 | $2.07M | <0.1% | 00.0% | Unchanged | History |
| BMYBristol Myers Squibb Co | Stock | 47,613 | $2.15M | <0.1% | +10,436+28.1% | Added | History |
| ILMNIllumina, Inc. | COM | 23,797 | $2.26M | <0.1% | −3,827−13.9% | Reduced | History |
| ADPTAdaptive Biotechnologies Corp | COM | 168,476 | $2.52M | 0.1% | +168,476 | New | History |
| CAHCardinal Health Inc | Stock | 16,268 | $2.55M | 0.1% | −3,744−18.7% | Reduced | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 35,644 | $2.73M | 0.1% | −2,756−7.2% | Reduced | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 84,976 | $2.77M | 0.1% | −462−0.5% | Reduced | History |
| NEONeogenomics Inc | COM NEW | 370,198 | $2.86M | 0.1% | −542,884−59.5% | Reduced | History |
| MRKMerck & Co., Inc. | Stock | 34,739 | $2.92M | 0.1% | +6,500+23.0% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 20,251 | $2.92M | 0.1% | −61,146−75.1% | Reduced | History |
| KMTSKestra Medical Technologies, Ltd. | SHS | 128,711 | $3.06M | 0.1% | −5,050−3.8% | Reduced | History |
| BNTXBioNTech SE | SPONSORED ADS | 33,955 | $3.35M | 0.1% | −1,084−3.1% | Reduced | History |
| TXG10x Genomics, Inc. | CL A COM | 313,836 | $3.67M | 0.1% | −12,915−4.0% | Reduced | History |
| CVSCVS Health Corp | Stock | 51,199 | $3.86M | 0.1% | +21,103+70.1% | Added | History |
| AMGNAmgen Inc | Stock | 14,988 | $4.23M | 0.1% | −9,120−37.8% | Reduced | History |
| ICLRIcon PLC | COM | 24,247 | $4.24M | 0.1% | +24,247 | New | History |
| LHLabcorp Holdings Inc. | Stock | 15,065 | $4.32M | 0.1% | −21,627−58.9% | Reduced | History |
| INSPInspire Medical Systems, Inc. | COM | 58,648 | $4.35M | 0.1% | −17,012−22.5% | Reduced | History |
| SIBNSI-BONE, Inc. | COM | 298,857 | $4.40M | 0.1% | −241,255−44.7% | Reduced | History |
| GKOSGLAUKOS Corp | COM | 55,926 | $4.56M | 0.1% | 00.0% | Unchanged | History |
| WAYWaystar Holding Corp. | COM | 129,913 | $4.93M | 0.1% | −20,697−13.7% | Reduced | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 24,903 | $4.95M | 0.1% | −3,752−13.1% | Reduced | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 101,033 | $5.47M | 0.1% | −50,412−33.3% | Reduced | History |
| GILDGilead Sciences, Inc. | Stock | 49,893 | $5.54M | 0.1% | −1,523−3.0% | Reduced | History |
| OMDAOmada Health, Inc. | COM | 251,791 | $5.57M | 0.1% | +1,791+0.7% | Added | History |
| BTSGBrightSpring Health Services, Inc. | COM | 190,524 | $5.63M | 0.1% | −1,182−0.6% | Reduced | History |
| DGXQuest Diagnostics Inc | COM | 33,015 | $6.29M | 0.1% | −15,552−32.0% | Reduced | History |
| AXSMAxsome Therapeutics, Inc. | COM | 52,335 | $6.36M | 0.1% | −3,918−7.0% | Reduced | History |
| PHRPhreesia, Inc. | COM | 313,057 | $7.36M | 0.2% | −18,959−5.7% | Reduced | History |
| THCTenet Healthcare Corp | COM NEW | 40,372 | $8.20M | 0.2% | +40,372 | New | History |
| CDNACareDx, Inc. | COM | 572,956 | $8.33M | 0.2% | −179,415−23.8% | Reduced | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 15,057 | $8.47M | 0.2% | −11,687−43.7% | Reduced | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 424,056 | $8.57M | 0.2% | +2,555+0.6% | Added | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 315,857 | $8.84M | 0.2% | −32,670−9.4% | Reduced | History |
| IQVIQVIA Holdings Inc. | Stock | 52,898 | $10.0M | 0.2% | +19,198+57.0% | Added | History |
| CNCCentene Corp | Stock | 281,949 | $10.1M | 0.2% | +142,639+102.4% | Added | History |
| ONCBeOne Medicines Ltd. | ADR | 33,797 | $11.5M | 0.2% | −4,901−12.7% | Reduced | History |
| TMDXTransMedics Group, Inc. | COM | 116,968 | $13.1M | 0.3% | −13,549−10.4% | Reduced | History |
| EXASExact Sciences Corp | COM | 252,701 | $13.8M | 0.3% | −31,500−11.1% | Reduced | History |
| JNJJohnson & Johnson | Stock | 74,807 | $13.9M | 0.3% | +6,596+9.7% | Added | History |
| MASIMasimo Corp | COM | 96,968 | $14.3M | 0.3% | +7,295+8.1% | Added | History |
| NTRANatera, Inc. | COM | 91,818 | $14.8M | 0.3% | −55,673−37.7% | Reduced | History |
| EHCEncompass Health Corp | COM | 122,958 | $15.6M | 0.3% | −8,783−6.7% | Reduced | History |
| ANNXAnnexon, Inc. | COM | 5,157,290 | $15.7M | 0.3% | 00.0% | Unchanged | History |
| PRCTPROCEPT BioRobotics Corp | COM | 463,404 | $16.5M | 0.3% | −25,874−5.3% | Reduced | History |
| PRVAPrivia Health Group, Inc. | COM | 666,177 | $16.6M | 0.3% | +35,480+5.6% | Added | History |
| MGNXMacrogenics Inc | COM | 9,919,992 | $16.7M | 0.3% | 00.0% | Unchanged | History |
| HOLXHologic Inc | COM | 247,886 | $16.7M | 0.3% | 00.0% | Unchanged | History |
Sold out since Q2 2025 (11)
Positions held at the end of Q2 2025 that are gone from this filing.
| Security | Class | Shares in Q2 2025 | Value in Q2 2025 | % of portfolio in Q2 2025 | History |
|---|---|---|---|---|---|
| BPMCBlueprint Medicines Corp | COM | 284,900 | $36.5M | 0.8% | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 2,733,547 | $6.78M | 0.1% | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 15,927 | $1.51M | <0.1% | History |
| NVONovo Nordisk A S | ADR | 6,500 | $448.6K | <0.1% | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 24,008 | $336.6K | <0.1% | History |
| ADMAAdma Biologics, Inc. | COM | 16,900 | $307.7K | <0.1% | History |
| TVTXTravere Therapeutics, Inc. | COM | 18,303 | $270.9K | <0.1% | History |
| MTSRMetsera, Inc. | COM | 7,800 | $221.9K | <0.1% | History |
| BRBRBellring Brands, Inc. | Stock | 3,500 | $202.8K | <0.1% | History |
| ACLXArcellx, Inc. | COMMON STOCK | 3,000 | $197.6K | <0.1% | History |
| OCSOculis Holding AG | ORDINARY SHARES | 9,700 | $188.3K | <0.1% | History |